Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2370-02 Phase 2 Study of Opicapone in Japanese Parkinson's Disease Patients With Motor Fluctuations
jRCT2080223058Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of opicapone in Parkinson's disease (PD) (4 arms), sponsored by Ono Pharmaceutical. Primary endpoint: Efficacy of opicapone versus placebo on OFF-time in double-blind phase. Started Dec 2015; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080223058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223058.